Robert has over 25 years of experience in life science instrumentation and product development. Before Halo, Robert was General Manager of Pall ForteBio responsible for growing the company with YOY growth of over 25% every year for four years. Robert was also the Senior VP of Instrumentation R&D at Pall Corporation and a corporate M&A member, helping acquire a variety of companies into Pall’s numerous markets. Before Pall, Robert was VP of Product Development and Operations for ForteBio from 2007 to 2012 where he helped exit the company to Pall Corporation for over $160M. Before that, Robert was at Molecular Devices Corporation, where he was Vice President of Product Development, being on the executive team that helped the $615M acquisition by MDS. Previously he was at Axon Instruments, Inc. for 13 years, as Vice President of Software Engineering, helping be the first private company to IPO on the Australian stock market, and then helped with the $140 million acquisition by Molecular Devices. Robert received a BA in Computer and Information Sciences and Mathematics from Drew University, NJ and an MS in Computer and Information Sciences from the University of Oregon.